Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood

Sucker, Christoph; Zacharowski, Kai; Thielmann, Matthias; Hartmann, Matthias
January 2007
Thrombosis Journal;2007, Vol. 5, p13
Academic Journal
Background: During gram-negative sepsis, lipopolysaccharide (LPS) induces tissue factor expression on monocytes. The resulting disseminated intravascular coagulation leads to tissue ischemia and worsens the prognosis of septic patients. There are indications, that fever reduces the mortality of sepsis, the effect on tissue factor activity on monocytes is unknown. Therefore, we investigated whether heat shock modulates LPS-induced tissue factor activity in human blood. Methods: Whole blood samples and leukocyte suspensions, respectively, from healthy probands (n = 12) were incubated with LPS for 2 hours under heat shock conditions (43°C) or control conditions (37°C), respectively. Subsequent to further 3 hours of incubation at 37°C the clotting time, a measure of tissue factor expression, was determined. Cell integrity was verified by trypan blue exclusion test and FACS analysis. Results: Incubation of whole blood samples with LPS for 5 hours at normothermia resulted in a significant shortening of clotting time from 357 ± 108 sec to 82 ± 8 sec compared to samples incubated without LPS (n = 12; p < 0.05). This LPS effect was mediated by tissue factor, as inhibition with active site-inhibited factor VIIa (ASIS) abolished the effect of LPS on clotting time. Blockade of protein synthesis using cycloheximide demonstrated that LPS exerted its procoagulatory effect via an induction of tissue factor expression. Upon heat shock treatment, the LPS effect was blunted: clotting times were 312 ± 66 s in absence of LPS and 277 ± 65 s in presence of LPS (n = 8; p > 0.05). Similarly, heat shock treatment of leukocyte suspensions abolished the LPS-induced tissue factor activity. Clotting time was 73 ± 31 s, when cells were treated with LPS (100 ng/mL) under normothermic conditions, and 301 ± 118 s, when treated with LPS (100 ng/mL) and heat shock (n = 8, p < 0.05). Control experiments excluded cell damage as a potential cause of the observed heat shock effect. Conclusion: Heat shock treatment inhibits LPS-induced tissue factor activity in human whole blood samples and isolated leukocytes.


Related Articles

  • Activation of the Coagullation Cascade in Patients with Leptospirosis. Chierakul, Wirongrong; Tientadakul, Panatsaya; Suputtamongkol, Yupin; Wuthiekanun, Vanaporn; Phimda, Kriangsak; Limpaiboon, Roongrueng; Opartkiattikul, Nisarat; White, Nicholas J.; Peacock, Sharon J.; Day, Nicholas P. // Clinical Infectious Diseases;1/15/2008, Vol. 46 Issue 2, p254 

    Background. Disseminated intravascular coagulation (DIG) is common among patients with sepsis. Leptospirosis is an important cause of sepsis in tropical areas, and pulmonary hemorrhage associated with thrombo-cytopenia is the major cause of death, but the coagulopathy in severe leptospirosis has...

  • The diagnostic role of procalcitonin in quinine-induced disseminated intravascular coagulation. POWELL, B.; SMITH, I. // Anaesthesia & Intensive Care;Jan2013, Vol. 41 Issue 1, p131 

    The article discusses a case of a 67-year-old man with quinine-induced disseminated intravascular coagulation (DIC). Particular focus is given to the ineffectiveness of procalcitonin (PCT) as a diagnostic tool for differentiating between quinine-induced DIC and sepsis. The patient presented with...

  • Procoagulant Activity in Trauma Patients. Wayne L. Chandler // American Journal of Clinical Pathology;Jul2010, Vol. 134 Issue 1, p90 

    Elevated levels of circulating procoagulants like tissue factor may increase the risk of systemic coagulation activation, thrombin generation, and consumptive coagulopathy. I measured procoagulant activity in plasma by using a clot-based assay that incorporated normal plasma to replace missing...

  • Microparticles during sepsis: target, canary or cure? Zafrani, Lara; Ince, Can; Yuen, Peter // Intensive Care Medicine;Oct2013, Vol. 39 Issue 10, p1854 

    In this article, the authors focus on a study by researcher X. Delabranche et al. related to the presence of microparticles (MPs) in patients suffering from sepsis as of 2013. They inform that MPs are small vesicles released by stress-activated cells and MPs promote tissue injury during sepsis....

  • Symmetrical peripheral gangrene: a rare but dreadful complication of sepsis. Parmar, Malvinder S. // CMAJ: Canadian Medical Association Journal;10/29/2002, Vol. 167 Issue 9, p1037 

    Looks at symmetrical peripheral gangrene (SPG) caused by septicemia. Details of case involving woman who had legs amputated below the knee because of SPG; Organisms involved in SPG; Aggravating factors of SPG; Mortality and amputation rates involved with SPG; How most SPG patients have...

  • Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor. Ueda, Chisato; Hirohata, Yoshihide; Kihara, Yasuyuki; Nakamura, Hayato; Abe, Shintaro; Akahane, Kazuhisa; Okamoto, Kohji; Itoh, Hideaki; Otsuki, Makoto // Journal of Gastroenterology;2001, Vol. 36 Issue 12, p848 

    A 54-year-old man was diagnosed as having pancreatic cancer and disseminated intravascular coagulation. His plasma tissue factor level on the 11th hospital day was 996 pg/ml (normal range, 120–270 pg/ml). He was treated with gabexate mesilate, antithrombin III, and low-molecular-weight...

  • A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Satoshi Gando; Daizoh Saitoh; Hiroyasu Ishikura; Masashi Ueyama; Yasuhiro Otomo; Shigeto Oda; Shigeki Kushimoto; Katsuhisa Tanjoh; Toshihiko Mayumi; Toshiaki Ikeda; Toshiaki Iba; Yutaka Eguchi; Kohji Okamoto; Hiroshi Ogura; Kazuhide Koseki; Yuichiro Sakamoto; Yasuhiro Takayama; Kunihiro Shirai; Osamu Takasu; Yoshiaki Inoue // Critical Care;2013, Vol. 17 Issue 6, p1 

    Introduction To test the hypothesis that the administration of antithrombin concentrate improves disseminated intravascular coagulation (DIC), resulting in recovery from DIC and better outcomes in patients with sepsis, we conducted a prospective, randomized controlled multicenter trial at 13...

  • PERI OPERATIVE DISORDERS OF COAGULATION AND FIBRINOLYSIS IN PATIENTS SUBJECTED TO COLORECTAL CANCER RESECTION. Targoński, Ryszard; Cygański, Piotr; Kuciel-Lisiska, Grażyna; Drozdowski, Marek; Kaleczyc, Małgorzata; Sadowski, Janusz // Polish Annals of Medicine / Rocznik Medyczny;2011, Vol. 18 Issue 1, p52 

    Introduction. Venous thromboembolism and disseminated intravascular coagulation are frequent complications of malignant neoplasia. Abnormally high coagulationactivity and fibrinolytic inhibition induced by surgery are suggested to be responsible for frequent occurrences of coagulative disorders....

  • Protein C Inhibitor as an Anti-Disseminated Intravascular Coagulation Agent - Mechanism and Modification. Fujita, M.; Izutani, W.; Takahashi, K. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Mar2004, Vol. 2 Issue 1, p21 

    Gram-negative sepsis is associated with disseminated intravascular coagulation (DIC) due to endothelial damage, which is induced by inflammatory mediators released from phagocytes activated by lipopolysaccharide (LPS). DIC is a systemic hemorrhagic syndrome, which results from the consumption of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics